Gyre Therapeutics (GYRE) Gross Profit (2020 - 2026)
Gyre Therapeutics (GYRE) posted Gross Profit of $26.9 million for Q2 2026, up 5.0% from $25.62 million a year earlier and up 26.3% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Gross Profit (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Profit at Gyre Therapeutics was $112.58 million, up 14.9% year-over-year; for FY2025, it was $111.17 million, up 9.1% from FY2024.
- Annual Gross Profit shows a five-year compound annual growth rate of 56.7% (FY2020 to FY2025).
- In prior years, Gyre Therapeutics' Gross Profit was $101.87 million in FY2024 (-6.4%), $108.81 million in FY2023 (+11.6%), $97.5 million in FY2022 and -$42,000 in FY2021.
- Quarterly Gross Profit has run from a low of -$14,000 in Q4 2021 to a high of $97.5 million in Q4 2022 over five years.
- On a year-over-year basis, Gross Profit has increased in each of the last five quarters, with growth averaging 3.1% over the last eight quarters.
- The strongest year-over-year quarter for Gross Profit in the past five years was Q4 2025, with growth of 32.8%; the weakest was Q4 2023, with a decline of 73.4%.
- According to Business Quant data, Gross Profit for the three prior quarters was $21.29 million (Q1 2026), $35.45 million (Q4 2025) and $28.94 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Gyre Therapeutics | 753.90 Mn | 556.61 Mn | 26.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.90 Mn |
| Mar 31, 2026 | 21.29 Mn |
| Dec 31, 2025 | 35.45 Mn |
| Sep 30, 2025 | 28.94 Mn |
| Jun 30, 2025 | 25.62 Mn |
| Mar 31, 2025 | 21.16 Mn |
| Dec 31, 2024 | 26.70 Mn |
| Sep 30, 2024 | 24.53 Mn |
| Jun 30, 2024 | 24.46 Mn |
| Mar 31, 2024 | 26.19 Mn |
| Dec 31, 2023 | 25.90 Mn |
| Sep 30, 2023 | 30.86 Mn |
| Jun 30, 2023 | 28.25 Mn |
| Mar 31, 2023 | 23.81 Mn |
| Dec 31, 2022 | 97.50 Mn |
| Mar 31, 2022 | -4,000.00 |
| Dec 31, 2021 | -14,000.00 |
| Sep 30, 2021 | -8,000.00 |
| Jun 30, 2021 | -7,000.00 |
| Mar 31, 2021 | -13,000.00 |
API Access
Gyre Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();